Effects of hepatitis B virus on Th17, Treg and Th17/Treg ratio in different alanine aminetransferase stages.
- Author:
Peng GAO
1
;
Yan Ping LUO
2
;
Jun Feng LI
1
;
Iin CHEN
3
;
Xiao Rong MAO
3
Author Information
1. Infectious Disease Research Institute, First Hospital of Lanzhou University, Lanzhou 730000, China.
2. Department of Immunology, Medicine College of Lanzhou University, Lanzhou 730000, China.
3. Department of Infection, First Hospital of Lanzhou University, Lanzhou 730000, China.
- Publication Type:Journal Article
- Keywords:
Chronic hepatitis B;
Th17 cells;
Treg cells;
Viral load
- MeSH:
Alanine/therapeutic use*;
Alanine Transaminase/therapeutic use*;
Antiviral Agents/therapeutic use*;
DNA, Viral/therapeutic use*;
Hepatitis B/drug therapy*;
Hepatitis B virus/genetics*;
Hepatitis B, Chronic/drug therapy*;
Humans;
T-Lymphocytes, Regulatory
- From:
Journal of Peking University(Health Sciences)
2022;54(2):272-277
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the effects of hepatitis B virus (HBV) on helper T lymphocytes 17 (Th17), regulatory T lymphocyte (Treg) and Th17/Treg ratio in chronic hepatitis B patients in different alanine aminetransferase (ALT) stages.
METHODS:In the study, 336 chronic hepatitis B patients in the first hospital of Lanzhou University were analyzed. The hepatitis B antigen antibody parameters were measured by chemiluminescence immunoassay analyzer, the liver function parameters were measured by automatic biochemical analyzer, the HBV loads were measured by quantitative PCR, Th17, Treg and Th17/Treg ratios were detected by flow cytometry. Among them, 111 cases (ALT < 40 U/L) of ALT were normal hepatitis B, 108 cases of chronic hepatitis B with ALT above normal upper limit and < 2 times higher (40 U/L≤ALT < 80 U/L), and 117 cases of chronic hepatitis B with ALT above 2 times normal upper limit (80 U/L≤ALT). According to the viral load, they were divided into low replication group with HBV DNA < 4.0 lg copies/mL, medium replication group with 4.0 lg copies/mL≤HBV DNA < 6.0 lg copies/mL and high replication group with HBV DNA ≥ 6.0 lg copies / mL. Dunnett T3 variance analysis were used to analyze the effects of HBV on Th17, Treg and Th17/Treg ratio in the chronic hepatitis B patients in different ALT stages. The changes of virological and immunological indexes before and after treatment were observed for 24 weeks of antiviral therapy in the hepatitis B patients with ALT≥double upper limit of normal group.
RESULTS:In the ALT normal group, different virus load HBV had minor effects on Th17, Treg and Th17/Treg ratio. In the ALT≥2 times upper limit of normal group, with the virus load increased, Th17 (3.18%±0.79% in low replication group, 3.78%±0.92% in medium replication group and 4.57%±1.15% in high replication group), Treg cells (5.52%±1.58% in low replication group, 5.89%±1.84% in medium replication group and 6.37%±2.35% in high replication group) and their ratio Th17/Treg (0.57±0.25 in low replication group, 0.65±0.29 in medium replication group and 0.73±0.36 in high replication group) were significantly increased (P < 0.05). After entecavir treatment 24 weeks, the patient' s HBV-DNA decreased significantly, Th17 (3.89%±1.02% vs. 2.06%±0.46%), Treg (6.02%±2.03% vs. 5.06%±1.25%), Th17/Treg ratio (0.65±0.28 vs. 0.41±0.14) decreased significantly (P < 0.05).
CONCLUSION:Investigation on the effects of HBV on Th17 and Treg cells and their ratios in different ALT states can clarify the effects of HBV on the body from the immunological perspective and can further understand the ALT grouping for antiviral treatment theoretical significance, which is helpful for clinical treatment.
